Antimicrobial stewardship in pediatrics: How every pediatrician can be a steward

JAMA Pediatrics

Volumn 167, Issue 9, 2013, Pages 859-866

  Hyun, David Y ^a,b   Hersh, Adam L ^c   Namtu, Katie ^d   Palazzi, Debra L ^e   Maples, Holly D ^f   Newland, Jason G ^g   Saiman, Lisa ^h  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

^e TEXAS CHILDREN S HOSPITAL   (United States)

^f UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^g UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^h Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; COTRIMOXAZOLE; VANCOMYCIN; VORICONAZOLE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ATTITUDE TO HEALTH; CLOSTRIDIUM DIFFICILE INFECTION; HEALTH CARE PLANNING; HEALTH PROGRAM; HUMAN; OUTCOME ASSESSMENT; PATIENT SAFETY; PEDIATRICIAN; PEDIATRICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TOTAL QUALITY MANAGEMENT;

ANTI-BACTERIAL AGENTS; ATTITUDE OF HEALTH PERSONNEL; DRUG MONITORING; DRUG RESISTANCE, BACTERIAL; GOVERNMENT REGULATION; HEALTH POLICY; HUMANS; INAPPROPRIATE PRESCRIBING; INFECTION CONTROL; PATIENT SAFETY; PEDIATRICS; PRACTICE GUIDELINES AS TOPIC; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; UNITED STATES;

EID: 84883527653     PISSN: 21686203     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2013.2241     Document Type: Review

References (59)

1. Elliott SP. Antimicrobial-resistant pathogens: an emerging pediatric threat. Adv Pediatr. 2008;55(1):329-348.
2. Bizzarro MJ, Gallagher PG. Antibiotic-resistant organisms in the neonatal intensive care unit. Semin Perinatol. 2007;31(1):26-32. (Pubitemid 46273660)
3. Blaschke AJ, Korgenski EK, Daly JA, LaFleur B, Pavia AT, Byington CL. Extended-spectrum beta-lactamase-producing pathogens in a children's hospital: a 5-year experience. Am J Infect Control. 2009;37(6):435-441.
4. Logan LK. Carbapenem-resistant enterobacteriaceae: an emerging problem in children. Clin Infect Dis. 2012;55(6):852-859.
5. Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: no ESKAPE! a update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(1):1-12.
6. Dellit TH, Owens RC, McGowan JE Jr, et al Infectious Diseases Society of America; Society for Healthcare Epidemiology of America. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159-177. (Pubitemid 46084814)
7. Hersh AL, Shapiro DJ, Pavia AT, Shah SS. Antibiotic prescribing in ambulatory pediatrics in the United States. Pediatrics. 2011;128(6):1053-1061.
8. Patel SJ, Larson EL, Kubin CJ, Saiman L. A review of antimicrobial control strategies in hospitalized and ambulatory pediatric populations. Pediatr Infect Dis J. 2007;26(6):531-537. (Pubitemid 46847316)
9. Society for Healthcare Epidemiology of America; Infectious Diseases Society of America; Pediatric Infectious Diseases Society. Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect Control Hosp Epidemiol. 2012;33(4):322-327.
10. Centers for Disease Control and Prevention. Get Smart: for outpatient providers. Centers for Disease Control and Prevention website. www.cdc.gov/getsmart/specific-groups/hcp/outpatient.html. Accessed November 12, 2012.
11. Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. Redbook: 2012 Report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2012.
12. Newland JG, Turgeon CE, Hedican EB, Hersh AL, Gerber JS, Weissman SJ. Widespread adoption of antimicrobial stewardship programs in children's hospitals [abstract]. Presented as a poster at: Annual Meeting of the Pediatric Academic Societies; April 30, 2012; Boston, Massachusetts. Abstract 3645.2.
13. Centers for Disease Control and Prevention. Get Smart: know when antibiotics work. For healthcare providers. Centers for Disease Control and Prevention website. www.cdc.gov/getsmart/specific-groups/hcp/index.html. Accessed November 12, 2012.
14. Amado VM, Vilela GP, Querioz A Jr, Amaral AC. Effect of a quality improvement intervention to decrease delays in antibiotic delivery in pediatric febrile neutropenia: a pilot study. J Crit Care. 2011;26(1):103.e9-103.e12. doi:10.1016/j.jcrc.2010.05.034.
15. van Vliet M, Potting CM, Sturm PD, Donnelly JP, Blijlevens NM. How prompt is prompt in daily practice? earlier initiation of empirical antibacterial therapy for the febrile neutropenic patient. Eur J Cancer Care (Engl). 2011;20(5):679-685.
16. Muszynski JA, Knatz NL, Sargel CL, Fernandez SA, Marquardt DJ, Hall MW. Timing of correct parenteral antibiotic initiation and outcomes from severe bacterial community-acquired pneumonia in children. Pediatr Infect Dis J. 2011;30(4):295-301.
17. Benin AL, Vitkauskas G, Thornquist E, et al. Improving diagnostic testing and reducing overuse of antibiotics for children with pharyngitis: a useful role for the electronic medical record. Pediatr Infect Dis J. 2003;22(12):1043-1047. (Pubitemid 37543399)
18. Gaur AH, Hare ME, Shorr RI. Provider and practice characteristics associated with antibiotic use in children with presumed viral respiratory tract infections. Pediatrics. 2005;115(3):635-641. (Pubitemid 43373023)
19. De Boeck K, Vermeulen F, Meyts I, Hutsebaut L, Franckaert D, Proesmans M. Coprescription of antibiotics and asthma drugs in children. Pediatrics. 2011;127(6):1022-1026.
20. Stallworth LE, Fick DM, Ownby DR, Waller JL. Antibiotic use in children who have asthma: results of retrospective database analysis. J Manag Care Pharm. 2005;11(8):657-662.
21. Arnold SR, Straus SE. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev. 2005;19(4):CD003539.
22. Samore MH, Bateman K, Alder SC, et al. Clinical decision support and appropriateness of antimicrobial prescribing: a randomized trial. JAMA. 2005;294(18):2305-2314. (Pubitemid 41607406)
23. Kuti EL, Patel AA, Coleman CI. Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: ameta-analysis. J Crit Care. 2008;23(1):91-100. (Pubitemid 351400347)
24. Kumar A, Ellis P, Arabi Y, et al Cooperative Antimicrobial Therapy of Septic Shock Database Research Group. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest. 2009;136(5):1237-1248.
25. Lee CC, Lee CH, Chuang MC, Hong MY, Hsu HC, Ko WC. Impact of inappropriate empirical antibiotic therapy on outcome of bacteremic adults visiting the ED. Am J Emerg Med. 2012;30(8):1447-1456.
26. Shorr AF, Micek ST, Welch EC, Doherty JA, Reichley RM, Kollef MH. Inappropriate antibiotic therapy in gram-negative sepsis increases hospital length of stay. Crit Care Med. 2011;39(1):46-51.
27. Brusselaers N, Vogelaers D, Blot S. The rising problem of antimicrobial resistance in the intensive care unit. Ann Intensive Care. 2011;1:47. doi:10.1186/2110-5820-1-47.
28. Boggan JC, Navar-Boggan AM, Jhaveri R. Pediatric-specific antimicrobial susceptibility data and empiric antibiotic selection. Pediatrics. 2012;130(3):e615-e622. doi:10.1542/peds.2012-0563.
29. Hebert C, Ridgway J, Vekhter B, Brown EC, Weber SG, Robicsek A. Demonstration of the weighted-incidence syndromic combination antibiogram: an empiric prescribing decision aid. Infect Control Hosp Epidemiol. 2012;33(4):381-388.
30. Dahle KW, Korgenski EK, Hersh AL, Srivastava R, Gesteland PH. Clinical value of an ambulatory-based antibiogram for uropathogens in children. J Pediatric Infect Dis Soc. 2012;1(4):333-336.
31. Paul M, Soares-Weiser K, Leibovici L. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis. BMJ. 2003;326(7399):1111. doi:http://dx.doi.org/10.1136/bmj.326.7399.1111.
32. Di Pentima MC, Chan S. Impact of antimicrobial stewardship program on vancomycin use in a pediatric teaching hospital. Pediatr Infect Dis J. 2010;29(8):707-711.
33. Di Pentima MC, Chan S, Hossain J. Benefits of a pediatric antimicrobial stewardship program at a children's hospital. Pediatrics. 2011;128(6):1062-1070.
34. Di Pentima MC, Chan S, Eppes SC, Klein JD. Antimicrobial prescription errors in hospitalized children: role of antimicrobial stewardship program in detection and intervention. Clin Pediatr (Phila). 2009;48(5):505-512.
35. Stulberg JJ, Delaney CP, Neuhauser DV, Aron DC, Fu P, Koroukian SM. Adherence to surgical care improvement project measures and the association with postoperative infections. JAMA. 2010;303(24):2479-2485.
36. Metjian TA, Prasad PA, Kogon A, Coffin SE, Zaoutis TE. Evaluation of an antimicrobial stewardship program at a pediatric teaching hospital. Pediatr Infect Dis J. 2008;27(2):106-111.
37. National Healthcare Safety Network. Medication-associated module. Centers for Disease Control and Prevention website. www.cdc.gov/nhsn/psc-ma.html. Accessed November 12, 2012.
38. Hersh AL, Beekmann SE, Polgreen PM, Zaoutis TE, Newland JG. Antimicrobial stewardship programs in pediatrics. Infect Control Hosp Epidemiol. 2009;30(12):1211-1217.
39. Stevenson KB, Balada-Llasat JM, Bauer K, et al. The economics of antimicrobial stewardship: the current state of the art and applying the business case model. Infect Control Hosp Epidemiol. 2012;33(4):389-397.
40. Shrestha NK, Bhaskaran A, Scalera NM, Schmitt SK, Rehm SJ, Gordon SM. Contribution of infectious disease consultation toward the care of inpatients being considered for community-based parenteral anti-infective therapy. J Hosp Med. 2012;7(5):365-369.
41. Talpaert MJ, Gopal Rao G, Cooper BS, Wade P. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother. 2011;66(9):2168-2174.
42. Nathwani D, Sneddon J, Malcolm W, et al Scottish Antimicrobial Prescribing Group. Scottish Antimicrobial Prescribing Group (SAPG): development and impact of the Scottish National Antimicrobial Stewardship Programme. Int J Antimicrob Agents. 2011;38(1):16-26.
43. Valiquette L, Cossette B, Garant MP, Diab H, Pépin J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis. 2007;45(suppl 2):S112-S121. (Pubitemid 47328625)
44. McGowan JE Jr. Antimicrobial stewardship: the state of the art in 2011: focus on outcome and methods. Infect Control Hosp Epidemiol. 2012;33(4):331-337.
45. Davey P, Brown E, Fenelon L, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2005;(4):CD003543.
46. Davey P, Sneddon J, Nathwani D. Overview of strategies for overcoming the challenge of antimicrobial resistance. Expert Rev Clin Pharmacol. 2010;3(5):667-686.
47. Kaki R, Elligsen M, Walker S, Simor A, Palmay L, Daneman N. Impact of antimicrobial stewardship in critical care: a systematic review. J Antimicrob Chemother. 2011;66(6):1223-1230.
48. Nowak MA, Nelson RE, Breidenbach JL, Thompson PA, Carson PJ. Clinical and economic outcomes of a prospective antimicrobial stewardship program. Am J Health Syst Pharm. 2012;69(17):1500-1508.
49. Fishman N. Antimicrobial stewardship. Am J Med. 2006;119(6)(suppl 1):S53-S70.
50. Bartlett JG. A call to arms: the imperative for antimicrobial stewardship. Clin Infect Dis. 2011;53(S1)(suppl 1):S4-S7.
51. Hyle EP, Bilker WB, Gasink LB, Lautenbach E. Impact of different methods for describing the extent of prior antibiotic exposure on the association between antibiotic use and antibiotic-resistant infection. Infect Control Hosp Epidemiol. 2007;28(6):647-654. (Pubitemid 46954748)
52. Tacconelli E, De Angelis G, Cataldo MA, Pozzi E, Cauda R. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? a systematic review and meta-analysis. J Antimicrob Chemother. 2008;61(1):26-38.
53. Ohl CA, Dodds Ashley ES. Antimicrobial stewardship programs in community hospitals: the evidence base and case studies. Clin Infect Dis. 2011;53(suppl 1):S23-S30.
54. Lee SO, Lee ES, Park SY, Kim SY, Seo YH, Cho YK. Reduced use of third-generation cephalosporins decreases the acquisition of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol. 2004;25(10):832-837. (Pubitemid 40036758)
55. Lipworth AD, Hyle EP, Fishman NO, et al. Limiting the emergence of extended-spectrum Beta-lactamase-producing enterobacteriaceae: influence of patient population characteristics on the response to antimicrobial formulary interventions. Infect Control Hosp Epidemiol. 2006;27(3):279-286.
56. Carling P, Fung T, Killion A, Terrin N, Barza M. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol. 2003;24(9):699-706. (Pubitemid 37221343)
57. Rahal JJ, Urban C, Segal-Maurer S. Nosocomial antibiotic resistance in multiple gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites. Clin Infect Dis. 2002;34(4):499-503. (Pubitemid 34112271)
58. Ding H, Yang Y, Wei J, et al. Influencing the use of antibiotics in a Chinese pediatric intensive care unit. Pharm World Sci. 2008;30(6):787-793.
59. California Health and Safety Code §1288.45-1288.9. www.leginfo.ca.gov/cgi-bin/displaycode?section=hsc&group= 01001-02000&file=1288.45-1288.9. Accessed June 7, 2013.